SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-578754
Filing Date
2016-05-05
Accepted
2016-05-05 08:01:59
Documents
36
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d184261d10q.htm 10-Q 185821
2 EX-31.1 d184261dex311.htm EX-31.1 8654
3 EX-31.2 d184261dex312.htm EX-31.2 8652
4 EX-32.1 d184261dex321.htm EX-32.1 4663
  Complete submission text file 0001193125-16-578754.txt   1570062

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT meip-20160331.xml EX-101.INS 173985
6 XBRL TAXONOMY EXTENSION SCHEMA meip-20160331.xsd EX-101.SCH 21252
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE meip-20160331_cal.xml EX-101.CAL 25639
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE meip-20160331_def.xml EX-101.DEF 141328
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20160331_lab.xml EX-101.LAB 213201
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20160331_pre.xml EX-101.PRE 162751
Mailing Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50484 | Film No.: 161621629
SIC: 2834 Pharmaceutical Preparations